Skip to main content

Table 4 Participant anthropometric indicator changes before and after intervention

From: The effects of a low carbohydrate diet combined with partial meal replacement on obese individuals

  

Control group

Intervention group 1

Intervention group 2

P (total)

P(Intervention group 1/ Control group)

P(Intervention group 2/ Control group)

P(Intervention group 1/ Intervention group 2)

Weight (kg)

Baseline a

90.10 ± 10.62

88.12 ± 8.51

89.71 ± 12.31

0.724

0.449

0.880

0.544

Week 4 a

90.68 ± 9.94

86.62 ± 9.06

88.09 ± 12.12

0.283

0.118

0.317

0.568

Week 13 a

90.88 ± 9.76

85.02 ± 9.38

87.15 ± 11.92

0.074

0.024

0.149

0.407

4-week variation a

-0.16 ± 1.64

-1.50 ± 2.37

-2.19 ± 2.08

< 0.001

0.009

< 0.001

0.174

13 week variation b

0.20 ± 4.00

-4.00 ± 5.00

-1.90 ± 3.40

< 0.001

< 0.001

0.003

0.731

BMI(kg/m2)

Baseline b

30.20 ± 3.80

30.53 ± 2.80

30.50 ± 2.70

0.544

0.873

0.480

0.251

Week 4 b

30.80 ± 4.50

29.40 ± 2.90

30.10 ± 2.70

0.203

0.098

0.296

0.323

Week 13 a

30.84 ± 2.47

29.29 ± 2.40

29.96 ± 2.05

0.027

0.007

0.123

0.240

4-week variation a

-0.04 ± 0.55

-0.52 ± 0.81

-0.76 ± 0.69

< 0.001

0.006

< 0.001

0.159

13 week variation b

0.10 ± 1.30

-1.40 ± 1.80

-0.70 ± 1.30

< 0.001

< 0.001

0.002

0.740

Waist circumference (cm)

Baseline c

101.42 ± 7.51

102.41 ± 4.93

102.30 ± 7.78

0.806

0.485

0.677

0.969

Week 4 a

100.47 ± 7.10

99.72 ± 5.68

99.17 ± 8.70

0.766

0.674

0.468

0.760

Week 13 a

99.63 ± 7.38

94.96 ± 6.20

96.56 ± 9.51

0.052

0.017

0.114

0.408

4-week variation a

-0.97 ± 3.58

-2.69 ± 4.77

-3.38 ± 4.60

0.073

0.111

0.027

0.522

13 week variation b

-1.00 ± 5.40

-8.00 ± 7.40

-7.10 ± 8.00

< 0.001

< 0.001

0.002

1.000

Hip circumference (cm)

Baseline a

109.27 ± 5.96

109.60 ± 4.49

110.44 ± 5.28

0.651

0.798

0.370

0.521

Week 4 a

109.23 ± 5.66

108.09 ± 5.32

107.59 ± 4.40

0.421

0.374

0.200

0.693

Week 13 a

109.12 ± 5.72

105.10 ± 4.69

106.84 ± 5.53

0.011

0.003

0.085

0.188

4-week variation a

-0.49 ± 3.39

-1.51 ± 4.33

-2.60 ± 4.63

0.126

0.324

0.042

0.288

13 week variation a

-0.36 ± 3.51

-5.13 ± 5.02

-3.21 ± 4.78

< 0.001

< 0.001

0.011

0.085

Systolic blood pressure (mm Hg)

Baseline b

133.00 ± 15.00

130.00 ± 19.00

123.00 ± 21.00

0.257

0.663

0.133

0.202

Week 4 b

128.00 ± 16.00

127.00 ± 18.00

126.00 ± 13.00

0.937

0.672

0.873

0.954

Week 13 b

133.00 ± 11.00

125.00 ± 15.00

124.00 ± 14.00

0.018

0.034

0.051

1.000

4-week variation b

-4.00 ± 12.00

-6.00 ± 13.00

0.00 ± 16.00

0.221

0.480

0.296

0.088

13 week variation b

-1.00 ± 14.00

-5.00 ± 14.00

-4.00 ± 14.00

0.048

0.044

0.404

1.000

Diastolic pressure (mm Hg)

Baseline b

84.00 ± 16.00

87.00 ± 25.00

81.00 ± 18.00

0.392

0.530

0.430

0.182

Week 4 b

85.00 ± 15.00

85.00 ± 16.00

83.00 ± 12.00

0.432

0.878

0.275

0.255

Week 13 b

86.00 ± 12.00

82.00 ± 7.00

84.00 ± 11.00

0.180

0.165

0.073

0.903

4-week variation b

-1.00 ± 7.00

-2.00 ± 10.00

-2.00 ± 11.00

0.619

0.500

0.738

0.352

13 week variation b

1.00 ± 9.00

-3.00 ± 12.00

-1.00 ± 4.00

0.023

0.018

0.419

0.618

  1. aNormal variance was homogeneous and expressed by the mean ± standard deviation (X ± S). Single factor analysis of variance was used for comparisons between groups
  2. bSkewness distribution was expressed by the median ± interquartile interval (Me ± IQR). Rank sum tests were used for comparisons between groups
  3. cIf the normal variance is uneven, it is expressed by the mean ± standard deviation (X ± S). Rank sum tests were used for inter-group comparisons